Early Partnerships & Transactions Lead

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

Could you be our next Senior Director, Early Partnerships Lead? The job is in our King of Prussia PA or Waltham MA Office. This is a hybrid position and is onsite three days a week.

Lead deal maker for early-stage external innovation opportunities, including MTAs, research collaborations, and creative partnership structures. This role requires a strong business development background in pharma, a proven track record of innovative deal-making, and the ability to shape strategies that create competitive advantage in onboarding and advancing external assets.

• Lead Early-Stage Deal-Making:
  Drive MTAs, research collaborations, options-to-license, and other innovative structures to accelerate external innovation.

• Source Strategic Assets:
  Partner with big pharma BD teams to identify and onboard deprioritized assets; maintain strong relationships with academia, biotech, and investors.

• Develop Partnership Strategy:
  Create onboarding advantages and transaction pathways that position the organization as a preferred partner.

• Align and Influence:
  Communicate deal vision and strategic rationale internally; collaborate with BD to amplify priorities to banks, VCs, and the investment community.

• Innovate Models:
  Design new partnership and funding approaches to expand deal-making capabilities.

• Ensure Governance & Performance for Early Partnerships:
  Set success metrics, monitor progress, and deliver value through disciplined execution.

• 15+ years in biopharma business development, alliance management, or external innovation roles, with 10+ years in senior leadership positions.

• Demonstrated success in structuring and closing complex deals, including early-stage collaborations and creative funding models.

• Strong network within pharma BD organizations, biotech, and investment communities.

• Advanced degree preferred (MBA, PhD, or equivalent).

• Exceptional negotiation, relationship-building, and strategic thinking skills.

#LI-HYBRID

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit  and CSL Plasma at

For more information on CSL benefits visit

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit